Our results obtained in isogenic CLL-derived cell lines provide a more comprehensive landscape of the role of each CLL BIRC3-related alterations in the non-canonical NF-κB pathway, complementing previous findings hinted in a panel of lymphoid-related cell lines [18]. The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.